Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In vivo induction of heme oxygenase-1 (HO-1) in the metabolic syndrome
2010-020875-22Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of heme arginate in cardiometabolic risk (CMR) and insulin resistance (IR), sponsored by Radboud University Medical Center. Primary endpoint: Insulin sensitivity. Started Jun 2010; status: completed.
02
Drugs
heme arginate
03
Conditions
cardiometabolic risk (CMR)insulin resistance (IR)
Beyond the preview
Go deeper on 2010-020875-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020875-22.